See more : L.G. Balakrishnan & Bros Limited (LGBBROSLTD.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Columbia Care Inc. (CCHWF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Columbia Care Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Acerus Pharmaceuticals Corporation (ASPCF) Income Statement Analysis – Financial Results
- The Quarto Group, Inc. (QRT.L) Income Statement Analysis – Financial Results
- TD Holdings, Inc. (GLG) Income Statement Analysis – Financial Results
- Hilton Food Group plc (HFG.L) Income Statement Analysis – Financial Results
- Stellantis N.V. (STLA.PA) Income Statement Analysis – Financial Results
Columbia Care Inc. (CCHWF)
About Columbia Care Inc.
Columbia Care Inc. cultivates, manufactures, and provides cannabis products and related services. It offers flowers, edibles, oils, and tablets under the Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of June 15, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|
Revenue | 511.58M | 460.08M | 179.50M | 77.46M | 0.00 |
Cost of Revenue | 310.37M | 266.07M | 113.53M | 40.60M | 0.00 |
Gross Profit | 201.21M | 194.02M | 65.98M | 36.86M | 0.00 |
Gross Profit Ratio | 39.33% | 42.17% | 36.76% | 47.59% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 203.69M | 179.48M | 118.34M | 105.44M | 0.00 |
Selling & Marketing | 14.17M | 16.26M | 6.08M | 5.79M | 0.00 |
SG&A | 617.45M | 195.73M | 124.42M | 111.24M | 0.00 |
Other Expenses | -16.45M | 36.32M | 15.65M | 7.45M | 0.00 |
Operating Expenses | 617.45M | 232.05M | 140.07M | 118.68M | 0.00 |
Cost & Expenses | 927.82M | 498.12M | 253.60M | 159.28M | 0.00 |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 53.90M | 30.01M | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 84.79M | 53.00M | 42.02M | 26.26M | 161.14K |
EBITDA | -416.24M | 13.64M | -32.08M | -55.56M | 0.00 |
EBITDA Ratio | -81.36% | 2.96% | -17.87% | -71.73% | 0.00% |
Operating Income | -416.24M | -39.37M | -74.10M | -81.82M | 0.00 |
Operating Income Ratio | -81.36% | -8.56% | -41.28% | -105.63% | 0.00% |
Total Other Income/Expenses | -16.45M | -107.35M | -62.77M | -12.04M | 0.00 |
Income Before Tax | -432.69M | -146.71M | -136.87M | -93.85M | 0.00 |
Income Before Tax Ratio | -84.58% | -31.89% | -76.25% | -121.17% | 0.00% |
Income Tax Expense | -11.21M | 139.00K | -3.67M | 12.87M | 0.00 |
Net Income | -421.48M | -146.85M | -133.20M | -106.73M | 0.00 |
Net Income Ratio | -82.39% | -31.92% | -74.20% | -137.79% | 0.00% |
EPS | -1.16 | -0.43 | -0.57 | -0.51 | 0.00 |
EPS Diluted | -1.16 | -0.43 | -0.57 | -0.51 | 0.00 |
Weighted Avg Shares Out | 363.17M | 338.75M | 232.58M | 209.99M | 209.99M |
Weighted Avg Shares Out (Dil) | 363.17M | 338.75M | 232.58M | 209.99M | 209.99M |
New York cannabis regulators vote to allow multistate operators into the market
Columbia Care Announces Upcoming Conference Participation
Cannabis MSO winning streak expected to continue as lawmakers vote on SAFE Banking Act
Rosemary Mazanet, M.D., PhD. Joins Columbia Care's Board of Directors
Marijuana Stocks To Watch This Monday
HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain
Marijuana Penny Stocks for September Investment Watchlist
Top US Marijuana Stocks to Watch in Q3 2023: Promising Investment Opportunities
Top Marijuana Stocks To Buy For Future Gains
Columbia Care Inc. (CCHWF) Q2 2023 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports